Chariman and CEO Joseph C. Papa said Wednesday that he isn't too concerned about the future of the pharmaceutical industry despite pledges from Congress to lower the cost of prescription drugs.
Pharmaceuticals are "the most cost effective way" to treat and improve health care, Papa said in an interview with CNBC's Jim Cramer on "High prescription drug costs have become a rare bipartisan issue, with lawmakers on both sides of the aisle demanding changes. Democrats are jockeying to prove they can lead reform. President Donald Trump has made lowering prices one of the key issues of his administration, as health care remains a top issue for voters in the 2020 elections.
Papa joined Cramer after the company, formerly known as Valeant Pharmaceuticals, reported mixed second quarter financial results Tuesday. The company posted an earnings miss, while revenues rose by 1%. The Bausch & Lomb International business reported revenues of $1.2 billion during the second quarter, accounting for approximately 56% of the company's total revenue.for its DUOBRII lotion to treat plaque psoriasis. The drugmaker conducted two clinical trials, with 36% of patients in the first study and 45% in the second study seeing their skin clear up.
hydroxychloroquine uses https://keys-chloroquineclinique.com/
IFB TOYOGUAJARDO
What a relief so glad to hear LOL
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: CNBC - 🏆 12. / 72 Read more »
Source: HHSGov - 🏆 147. / 63 Read more »
Source: Health - 🏆 396. / 53 Read more »
Source: Health - 🏆 396. / 53 Read more »